yttrium radioisotopes has been researched along with Diarrhea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abecassis, M; Baker, T; Benson, AB; Desai, K; Gabr, A; Ganger, D; Gordon, AC; Hickey, R; Kallini, J; Kulik, L; Lewandowski, RJ; Miller, FH; Mouli, S; Mulcahy, MF; Rademaker, A; Salem, R; Sato, K; Thornburg, B; Yaghmai, V | 1 |
| Atassi, B; Benson, AB; Gates, VL; Gupta, R; Lewandowski, RJ; Memon, K; Miller, FH; Mulcahy, MF; Newman, S; Nikolaidis, P; Omary, RA; Riaz, A; Ryu, RK; Salem, R; Sato, KT; Yaghmai, V | 1 |
1 trial(s) available for yttrium radioisotopes and Diarrhea
| Article | Year |
|---|---|
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma.
Topics: Aged; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Diarrhea; Disease Progression; Disease-Free Survival; Ethiodized Oil; Female; Humans; Hypoalbuminemia; Intention to Treat Analysis; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Necrosis; Neoplasm Staging; Prospective Studies; Survival Rate; Yttrium Radioisotopes | 2016 |
1 other study(ies) available for yttrium radioisotopes and Diarrhea
| Article | Year |
|---|---|
Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.
Topics: Abdominal Pain; Aged; Analysis of Variance; Diarrhea; Embolization, Therapeutic; Fatigue; Female; Humans; Liver Neoplasms; Male; Microspheres; Middle Aged; Nausea; Neuroendocrine Tumors; Retrospective Studies; Survival Rate; Treatment Outcome; Vomiting; Weight Loss; Yttrium Radioisotopes | 2012 |